BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Atlanta Braves Holdings Series A
BATRA
$3.7B
| $30.9M | ﹤0.01% |
548,568
+18,690
| +4% | +$996K |
2016 Q2
40 quarters
|
|
2927
Puma Biotechnology
PBYI
$420M
| $30.9M | ﹤0.01% |
3,804,736
+205,784
| +6% | +$1.51M |
2013 Q2
52 quarters
|
|
2928
Immix Biopharma
IMMX
$692M
| $30.8M | ﹤0.01% |
2,989,972
+2,521,595
| +538% | +$23.4M |
2023 Q2
12 quarters
|
|
2929
Prudential
PUK
$31.5B
| $30.8M | ﹤0.01% |
1,149,155
-239,525
| -17% | -$6.99M |
2020 Q3
23 quarters
|
|
2930
Climb Global Solutions
CLMB
$805M
| $30.8M | ﹤0.01% |
1,326,018
+167,587
| +14% | +$3.59M |
2017 Q1
37 quarters
|
|
2931
Vitamin Cottage Natural Grocers
NGVC
$677M
| $30.8M | ﹤0.01% |
991,823
+65,475
| +7% | +$1.88M |
2013 Q2
52 quarters
|
|
2932
Clean Energy Fuels
CLNE
$404M
| $30.8M | ﹤0.01% |
15,005,980
-389,826
| -3% | -$828K |
2013 Q2
52 quarters
|
|
2933
Genesco
GCO
$398M
| $30.7M | ﹤0.01% |
909,991
+59,758
| +7% | +$2.1M |
2013 Q2
52 quarters
|
|
2934
Climb Bio
CLYM
$690M
| $30.7M | ﹤0.01% |
2,354,872
+1,953,223
| +486% | +$20.2M |
2021 Q3
19 quarters
|
|
2935
Northpointe Bancshares
NPB
$548M
| $30.6M | ﹤0.01% |
1,597,569
+206,069
| +15% | +$3.68M |
2025 Q1
5 quarters
|
|
2936
Vox Royalty Corp
VOXR
$338M
| $30.6M | ﹤0.01% |
6,472,292
+317,466
| +5% | +$1.75M |
2024 Q3
7 quarters
|
|
2937
Magnera Corp
MAGN
$465M
| $30.5M | ﹤0.01% |
2,596,578
+206,571
| +9% | +$2.26M |
2013 Q2
52 quarters
|
|
2938
BayCom
BCML
$342M
| $30.5M | ﹤0.01% |
926,776
+78,633
| +9% | +$2.41M |
2018 Q2
32 quarters
|
|
2939
Build-A-Bear
BBW
$371M
| $30.5M | ﹤0.01% |
995,791
+75,200
| +8% | +$2.7M |
2015 Q2
44 quarters
|
|
2940
The RMR Group
RMR
$269M
| $30.5M | ﹤0.01% |
1,483,326
+132,621
| +10% | +$2.51M |
2015 Q4
42 quarters
|
|
2941
Emera Inc
EMA
$15.7B
| $30.4M | ﹤0.01% |
574,221
+211,368
| +58% | +$11.1M |
2025 Q2
4 quarters
|
|
2942
Orthofix Medical
OFIX
$290M
| $30.4M | ﹤0.01% |
3,326,560
+118,771
| +4% | +$1.31M |
2013 Q2
52 quarters
|
|
2943
Tejon Ranch
TRC
$474M
| $30.4M | ﹤0.01% |
1,624,752
+68,197
| +4% | +$1.32M |
2013 Q2
52 quarters
|
|
2944
Vanguard Short-Term Bond ETF
BSV
$46.6B
| $30.4M | ﹤0.01% |
389,857
+3,642
| +0.9% | +$284K |
2025 Q2
4 quarters
|
|
2945
Ericsson
ERIC
$34.5B
| $30.2M | ﹤0.01% |
2,706,784
+1,571,627
| +138% | +$18.9M |
2020 Q3
23 quarters
|
|
2946
MVB Financial
MVBF
$333M
| $30.2M | ﹤0.01% |
1,039,372
+100,335
| +11% | +$2.67M |
2018 Q2
32 quarters
|
|
2947
Nice
NICE
$5.38B
| $30.1M | ﹤0.01% |
331,009
-105,921
| -24% | -$10.3M |
2020 Q3
23 quarters
|
|
2948
Keros Therapeutics
KROS
$183M
| $29.9M | ﹤0.01% |
2,794,217
+382,424
| +16% | +$4.26M |
2020 Q2
24 quarters
|
|
2949
AbCellera Biologics
ABCL
$4.04B
| $29.9M | ﹤0.01% |
3,805,309
-234,927
| -6% | -$1.15M |
2020 Q4
22 quarters
|
|
2950
American Battery Technology Co
ABAT
$188M
| $29.9M | ﹤0.01% |
10,552,173
+386,727
| +4% | +$1.24M |
2023 Q4
10 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.